You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: ZYMERON CORP            Topic: CBD181004

    Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. Stable Formulation of Nerve Agent Intoxication Countermeasures

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: CBD181005

    In response to the defined need for minimizing the carry weight of combat teams while retaining capability, Luna Innovations is proposing the development of a stable formulation of atropine and scopolamine for use in an autoinjector to combat nerve agent intoxication. The combined formulation of atropine and scopolamine will allow for better treatment with more physiological coverage within the hu ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  3. Bi-specific Antibodies Targeting Disease Caused by Encephalitic Alphaviruses

    SBC: BRHMS LLC            Topic: CBD181007

    Highly pathogenic alphaviruses like VEEV/EEV/WWEEV cause encephalitis in humans and equids. These infections are endemic in wide regions of the developing world. Translational research regarding these pathogens is focused on developing new strategies to detect, treat and ideally protect humans and animals from these infections. Gene-encoded antibodies against alphavirus E1/E2 surface proteins will ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  4. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: NANOHMICS INC            Topic: CBD171002

    For standoff chemical identification applications, the longwave infrared has several key lines for spectral discrimination. Unfortunately, most hyperspectral systems are quite large and fragile, making them unwieldy. Nanohmics proposes to demonstrate a chip-scale longwave infrared hyperspectral imaging technology. The weight and packaging volume will be dominated by the fore-optics instead of the ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  5. Self-Decontaminating Textiles

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: CBD161001

    Luna Innovations is addressing the need to develop novel fluid repellent textile treatments for military uniforms that will repel and actively decontaminate chemical and biological warfare agents (CBWA). There have been recent significant advances in textile treatments that have demonstrated water, oil and chemical agent resistance that are superior to Quarpel repellent treatments currently used o ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  6. Advanced Simulated Patient Intelligent Response Engine (ASPIRE)

    SBC: VCOM3D INC            Topic: DHA191002

    The goal of medical simulation-based training such as high-fidelity manikin simulators, part task trainers, and screen-based virtual patients, is to approximate real-life treatment experiences without risk to live patients. While the use of sensors has ma

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  7. nXcomms: Intelligent Patient Simulation

    SBC: BIOMOJO LLC            Topic: DHA191002

    BioMojo proposes to develop a language-based intelligent patient simulation platform for the purpose of providing students with a realistic training environment and instructors better control over the training environment involving simulated patients.

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  8. Intelligent Patient Simulation Platform

    SBC: SHARP VISION SOFTWARE LLC            Topic: DHA191002

    A proof-of-concept research on Intelligent Patient Platform is proposed with the goal to improve healthcare training experience by adding natural language capability to patient simulators by leveraging the latest artificial intelligent technologies so tha

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  9. Local Patient Record Transfer Modernization in Theater/Operational Settings in Support of JOMIS Patient Movement Requirements Definition Package (RDP) Requirements

    SBC: CONCENTRIS SYSTEMS LLC            Topic: DHP191003

    The DoD Medical Health Systems (MHS)seeksameans to collect, transport,and share patientcareinformation between disparateelectronicmedical record systems in austerelocations that lacksufficient or reliabletelecommunicationsconnectivity. Thesolution they seek must bereliablein deliveringlargeamounts of patient medical information, durablein demandingmilitaryenvironments,adaptableto current and evolv ...

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  10. Novel Fluorescence Lysosomal Yeast (FLY) Portable Biosensor for General Water Toxicity Testing

    SBC: NANOHMICS INC            Topic: DHA191006

    Nanohmics proposes to develop a radically new type of general water toxicity monitor based on the widely published principle that many eukaryotic (including yeast) cell lysosomes swell and increase in numbers in response to pollutants in water within 30-6

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government